AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(10 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
 
* ''AXA Full Year 2025'' earnings presentation delivered on February Earnings26, Presentation2026 <sup>p. 1</sup>
* February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* Certain statements are forward''Forward-looking, includingstatements'' predictionsinclude of future eventspredictions, trends, plans, expectations, or objectives based on Management's current views and subject to change <sup>p. 2</sup>.
* ''Expected UEPS growth'' for 2026 is provided as one-off guidance in the context of the final year of the Group's current strategic plan <sup>p. 2</sup>.
* Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' <sup>p. 2</sup>.
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* Statements regarding expected '''underlying earnings per share (UEPS) growth''' for 2026 are forward-looking, providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
** UndueAPMs relianceare shoulddefined notunder beESMA placedguidelines onand forward-lookingthe statementsAMF's due2015 toposition knownstatement, andwith unknownreconciliations risksprovided and uncertainties outsidein AXA's control2025 Activity Report <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
* Factors could cause AXA's actual results to differ materially from those expressed or implied <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and position <sup>p. 2</sup>.
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>.
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group's consolidated financial statements prepared in accordance with IFRS <sup>p. 2</sup>.
* '''Underlying earnings''', '''UEPS''' ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and AMF's related position statement issued in 2015 <sup>p. 2</sup>.
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on p.04 <sup>p. 3, 4</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on p.09 <sup>p. 3, 9</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on p.13 <sup>p. 3, 13</sup>.
 
== FY25 Highlights ==
 
* PresentedSection divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
{| class="wikitable fintable"
* '''ROE''' 16% in FY25 <sup>p. 5</sup>
*|+ '''UnderlyingKey EPS''' +8%financial vs.highlights, FY24FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
* '''Solvency II ratio''' 224% in FY25 <sup>p. 5</sup>
! class="col-m" style="text-align:right" | Value
* Delivering value for shareholders with +8% '''DPS''' growth and EUR 1.25bn annual share buyback <sup>p. 5</sup>
|-
** '''Dividend''' proposed by AXA's Board of Directors on February 25, 2026, subject to approval by Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>.
| style="text-align:left" | Revenues growth vs. FY24
** '''Share buyback''' approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>.
| style="text-align:right" | +6%
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS outlook for 2026
| style="text-align:right" | Upper end of 6%-8% target range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
 
=== Executing the plan on growth, margin and efficiency ===
Line 68 ⟶ 77:
{| class="wikitable fintable"
|+ Underlying earnings, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (constant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
| style="text-align:right" | +9%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* Underlying earnings +6% <sup>p. 6</sup>
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup>
* Scaling the business: Continued investments in growth and technology
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence
* Scaling the business: Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 88 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 100 ⟶ 111:
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
 
* Secular trends fueling demand across businesses <sup>p. 7</sup>
* Protection''Secular trends'' fuel demand across businesses, driven by protection gaps and emerging corporate risks, (relevantas forwell SMEas &demographics Mid-marketdriving anddemand Largefor &private Specialtyretirement segments) <sup>p.and 7</sup>healthcare
* ''Our right to win'' is supported by four strategic pillars:
* Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
** Leading brand & high customer NPS
* Our right to win <sup>p. 7</sup>
** Strong and diversified distribution
* Leading brand & high customer NPS <sup>p. 7</sup>
** Technical expertise to price & underwrite risks
* Strong and diversified distribution <sup>p. 7</sup>
** Scale offering cost advantage
* Technical expertise to price & underwrite risks <sup>p. 7</sup>
* Scale offering cost advantage <sup>p. 7</sup>
 
=== Laying the foundation for the next plan ===
 
* ''Strategic pillars'' established to lay the foundation for the next plan:
* (icon) '''Clear tech and AI roadmap''' <sup>p. 8</sup>
* (icon)* '''DrivingClear efficiency'tech'' and AI roadmap <sup>p. 8</sup>
** (icon)''Driving efficiency'''Enhancing capitalacross allocation discipline'''operations <sup>p. 8</sup>
* (icon)* '''BuildingEnhancing resilience'capital'' allocation discipline <sup>p. 8</sup>
** Confidence''Building inresilience'' sustainingacross earningsthe growthbusiness <sup>p. 8</sup>
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
== FY25 Business Performance ==
 
=== FY25 business performance ===
* Guillaume Borie <sup>p. 9</sup>
 
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
=== Strong delivery across our businesses ===
 
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross written premiums and underlying earnings by region, FY25 <sup>p. 10</sup>
! style="text-align:left" | EURRegion billion(share unlessof otherwisetotal mentionedGWP¹)
! class="col-sm" style="text-align:right" | GWPGross written premiums
! class="col-sm" style="text-align:right" | GWPUnderlying changeearnings
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change
! class="col-s" style="text-align:right" | % of total GWP
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | 31+6% to EUR 31bn
| class="col-m" style="text-align:right" | +67% to EUR 2.2bn
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | 43+6% to EUR 43bn
| class="col-m" style="text-align:right" | +69% to EUR 3.5bn
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
| style="text-align:right" | 38%
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | 19+4% to EUR 19bn
| class="col-m" style="text-align:right" | +49% to EUR 1.9bn
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
| style="text-align:right" | 17%
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | 20+13% to EUR 20bn
| class="col-m" style="text-align:right" | +136% to EUR 1.5bn
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
| style="text-align:right" | 18%
|}
</div>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers
 
=== P&C | Strong margins, confidence in sustaining growth ===
 
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
{| class="wikitable fintable"
|+** AXA XL GWP split,includes EURAXA 58bnXL totalRe premiums of EUR 2.6bn <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
! style="text-align:left" | Segment
* ''Retail and SME & Mid-market'' strategic outlook:
! class="col-s" style="text-align:right" | Share
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
| style="text-align:left" | Retail
* ''AXA XL (Large & Specialty)'' strategic outlook:
| style="text-align:right" | 34%
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
| style="text-align:left" | SME & Mid-market
* ''Earnings drivers'' supporting performance:
| style="text-align:right" | 33%
** Continued progress on efficiency <sup>p. 11</sup>.
|-
** Higher investment income <sup>p. 11</sup>.
| style="text-align:left" | AXA XL (Large & Specialty)
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
| style="text-align:right" | 33%
|}
</div>
* Underlying earnings +9% (FY25 vs. FY24 at constant FX) to EUR 5.9bn
* Includes AXA XL Re premiums of EUR 2.6bn
* '''2025 Strategic Focus'''
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins
** '''AXA XL''' (Large & Specialty): Profitable growth with stable margins
* '''Beyond 2025 Strategic Focus'''
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management
* '''Additional Strategic Initiatives'''
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience & technical excellence
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
{| class="wikitable fintable"
|* ''Underlying earnings'' +7% GWPLFL split,to EUR 57bn3.5bn total(change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
! style="text-align:left" | Segment
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
! class="col-s" style="text-align:right" | Share
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
|-
* ''Short-term business'' strategic priorities:
| style="text-align:left" | Short-term
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
| style="text-align:right" | 28%
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
|-
* ''Strategic levers'' for growth and efficiency:
| style="text-align:left" | Long-term
** Focus on cost reduction <sup>p. 12</sup>.
| style="text-align:right" | 72%
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
|}
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
</div>
 
* Underlying earnings +7% (FY25 vs. FY24 at constant FX) to EUR 3.5bn
== Financial Performance ==
* '''2025 Strategic Focus'''
** '''Long-term business''': Accelerating net flows in Savings at attractive margins
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact
* '''Beyond 2025 Strategic Focus'''
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins
* '''Additional Strategic Initiatives'''
** Focus on cost reduction
** Increasing penetration of Protection riders in Savings offerings
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health
 
=== FY25 Financialfinancial Performanceperformance ===
 
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
* Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 241 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by linesegment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" | —
| style="text-align:right" | 35.8
| style="text-align:right" | 35.8
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" | 2.6
| style="text-align:right" | 2.6
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | 18.1
| style="text-align:right" | 19.7
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Change at constant scope and FX <sup>p. 14</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Pricing
! class="col-s" style="text-align:right" | Volume
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" | +4%
| style="text-align:right" | +2%
Line 278 ⟶ 232:
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" | —
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
| style="text-align:right" | +0.3%
Line 283 ⟶ 239:
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | —
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
| style="text-align:right; font-weight:bold" | +5%
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|}
</div>
Line 292 ⟶ 257:
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
* (table) '''Change at constant scope and FX''' <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 298 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio bridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 323 ⟶ 287:
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total Combinedcombined Ratioratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* BetterUndiscounted undiscounted current yearCY loss ratio excluding(ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* ImprovementExpense inratio expense ratioimproved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Lower reliance on priorPrior year reserve development shows lower reliance
* TakingReserve prudence enhanced by taking advantage of a good year to enhance reserve prudence
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 340 ⟶ 304:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walkbridge, FY24 to FY25 <sup>p. 16</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying Earningsearnings
|-
| style="text-align:left" | FY24
Line 369 ⟶ 333:
|}
</div>
* Underlying Earningsearnings grew +9% (at constant FX) to EUR 5,872m.
* Better underwritingUnderwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* IncreaseInvestment inincome investment incomeincreased reflecting higher volumes and better reinvestment yields on fixed income assets.
* HigherInsurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* Unfavorable forexForex impact was unfavorable, notably due to USD depreciation vs. EUR.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 379 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP &and other revenues by line, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''Life GWP & Other Revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
Line 391 ⟶ 355:
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 17.3
| style="text-align:right" | 19.0
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | —
| style="text-align:right" | 9.3
| style="text-align:right" | 10.5
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | 6.0
| style="text-align:right" | 69.10
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.9
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left" | '''Health GWP & Other Revenues'''
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
Line 416 ⟶ 380:
|-
| style="text-align:left" | Individual
| style="text-align:right" | —
| style="text-align:right" | 10.5
| style="text-align:right" | 11.1
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
| style="text-align:right" | 7.0
| style="text-align:right" | 78.95
| style="text-align:right" | +4%
|-
| style="text-align:left" | Employee Benefits GWP
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
Line 429 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flowsFY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
 
* Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24
* Employee Benefits (short-term and long-term) FY25: EUR 12.9bn (+4% vs. FY24)
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
Line 457 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | '''Total PVEP'''
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
| style="text-align:right" | 39.4
| style="text-align:right" | 31.4
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | 8.5
| style="text-align:right" | 8.5
| style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:right" | 2.0
| style="text-align:right" | 7.8
| style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.0
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
Line 493 ⟶ 469:
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
|}
</div>
 
* ''PVEP was'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM was'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV was'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* (bar) '''NBNBV CSM'margin'': (pre-tax) +34.4% (constantin scopeFY24 → 4.5% andin FX)FY25 <sup>p. 18</sup>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 520 ⟶ 495:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Contractual Service MarginValue
|-
| style="text-align:left" | FY24
Line 550 ⟶ 525:
</div>
 
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
<div style="overflow-x:auto">
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
{| class="wikitable fintable"
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
|+ CSM by segment, FY24 vs FY25 <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
! style="text-align:left" | EUR billion
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Life
| style="text-align:right" | 25.8
| style="text-align:right" | 25.4
|-
| style="text-align:left" | Health
| style="text-align:right" | 7.7
| style="text-align:right" | 7.6
|}
</div>
 
* Normalized CSM up by +2% (constant scope and FX), with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
* Economic variance reflecting government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
* FX impact mainly from JPY and HKD depreciation
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 576 ⟶ 535:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings walkbridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 595 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* '''Underlying Earnings'earnings'' +7% (constantLFL to EUR FX)3,501m <sup>p. 20</sup>
* Strong '''shortShort-term technical margin''': reflectingEUR underwriting415m andin claimsFY24 initiativesto thatEUR more than offset the impact of legislative change on the recoverability of value added tax479m in Mexico (EUR -0.1bn)FY25 <sup>p. 20</sup>
* Higher '''longLong-term results'result'' from increase inincl. CSM release: (+8%)EUR reflecting growth2,680m in reserveFY24 base,to includingEUR from favorable equity market performance2,804m and betterin marginsFY25 <sup>p. 20</sup>
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
* '''Underlying Earnings by segment''':
** '''Life'Tax & others'': FY24 EUR 2.6bn,-748m FY25in FY24 to EUR 2.7bn-728m (+4%in vs. FY24)FY25 <sup>p. 20</sup>
** ''Life underlying earnings'Health''': FY24+4% to EUR 02.7bn, FY25(prior: EUR 02.8bn (+17% vs. FY246bn) <sup>p. 20</sup>
* '''Short-termHealth technicalunderlying margin'earnings'' +17% to EUR 0.8bn (prior: EUR 479m0.7bn) <sup>p. 20</sup>
* '''LongShort-term resultmargin'' incl.strong CSMon release''':underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR 2,804m-0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
* '''Financial result''': EUR 946m <sup>p. 20</sup>
* '''Tax & others''': -EUR 728m <sup>p. 20</sup>
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 615 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earningsEarnings and net income by segment,breakdown FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | Property & Casualty
Line 646 ⟶ 599:
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings total''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +26%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income total''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
Line 680 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share walkbridge, FY24 to FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Underlying earnings per share
Line 695 ⟶ 643:
| style="text-align:left" | Forex
| style="text-align:right" | -2%
|-
| style="text-align:left" | Temporary earnings dilution from AXA IM sale
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
Line 701 ⟶ 652:
</div>
 
* '''Underlying earnings''' drivers: Strong performance from insurance businesses <sup>p. 21</sup>
** '''UnderlyingStrong earnings''':performance Stablefrom holdinginsurance cost, expected to remain at current level in 2026businesses <sup>p. 21</sup>
** '''NetStable income''':holding Highercost, netexpected incometo mainlyremain reflectingat highercurrent underlyinglevel earningsin and the gain from the sale of AXA IM2026 <sup>p. 21</sup>
* ''Net income'' drivers:
* '''Net income''': Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
** ChangeHigher atnet constantincome FXmainly forreflecting higher underlying earnings and netthe incomegain from the sale of AXA IM <sup>p. 21</sup>
** ChangeLower onfinancial reportedflows basisreflecting forunfavorable underlyingforex earnings per shareimpact <sup>p. 21</sup>
* (bar)Change '''Underlyingis at constant FX for underlying earnings perand share''':net EURincome; 3.59change (FY24)is on EURa 3.86reported (FY25)basis (+8%)for underlying earnings per share <sup>p. 21</sup>
* including(bar) -1%''Underlying fromearnings temporaryper earningsshare'' dilution(In fromEuro): AXAEUR IM3.59 salein dueFY24 to theEUR timing3.86 ofin anti-dilutiveFY25 share buyback(+8%) <sup>p. 21</sup>
 
=== Shareholders' Equityequity ===
 
* (stacked bar) ''Shareholders' equity'' Group share:
<div style="overflow-x:auto">
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
{| class="wikitable fintable"
|+** Shareholders''HY25'': equityEUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and relatedNet OCI EUR metrics-7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | HY25
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity reconciliation, FY24 to FY25 and HY25 to FY25roll-forward <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | ''Opening Shareholders' equity''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 790 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" | ''Closing Shareholders' equity''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
 
* 1. Shareholders' equity Group share <sup>p. 22</sup>
* '''Shareholders' equity reconciliation''' (in Euro billion) <sup>p. 22</sup>
 
=== Higher organic cash remittance and robust cash position at Holding ===
 
* (bar) ''Net cash remittance'' trend:
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
** ''FY25'': EUR 7.5bn total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NetHolding Cashcash Remittanceposition and Cash Position,bridge FY24 vsto FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net''FY24 Cash Remittanceposition''
| style="text-align:right" | 74.70
| style="text-align:right" | 7.5
|-
| style="text-align:left" | RemittanceNet ratiocash remittance from subsidiaries
| style="text-align:right" | 82%+7.5
| style="text-align:right" | 82%
|-
| style="text-align:left" | Cash positionDividend
| style="text-align:right" | -4.06
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
| style="text-align:left" | Change in net debt
| style="text-align:right" | +1.6
|-
| style="text-align:left" | M&A and other
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
</div>
 
* FY24 Net Cash Remittance includes EUR 7.1bn (base) and EUR 0.6bn Proceeds related to in-force treaties².
* Net cash remittance from subsidiaries: +EUR 7.5bn
* Dividend: -EUR 4.6bn
* Annual share buyback: -EUR 1.2bn
* Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn
* Holding costs and interest expenses: -EUR 1.3bn
* Change in net debt: +EUR 1.6bn
* M&A and other: +EUR 3.1bn
* 1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25
* 2. EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe
 
=== Solvency II at 224% ===
Line 839 ⟶ 768:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
Line 863 ⟶ 792:
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
Line 884 ⟶ 813:
|}
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities onof Solvency II ratio as of December 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 906 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 923 ⟶ 855:
</div>
 
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Dividend & annual share buyback: Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
* 1. Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures)
* 2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches)
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 931 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio outlookimpacts <sup>p. 25</sup>
! style="text-align:left" | ItemEvent
! class="col-ms" style="text-align:right" | ValueImpact (pts)
|-
| style="text-align:left" | RatioSolvency II ratio as of December 31/12/, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Impact of theGrandfathering end of grandfathering periodimpact on January 1, 2026
| style="text-align:right" | -10pts to 215%10
|-
| style="text-align:left" | Impact of Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17pts17
|}
</div>
 
* EuroEUR 2.4 billion4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* AdditionalProvides additional capital flexibility.
* 1. Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* ''Section divider'' for the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
* Conclusion <sup>p. 26</sup>
* Thomas Buberl, Group CEO <sup>p. 26</sup>
 
=== Conclusion ===
 
* '''Record results''', achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* ''Q&A session'' for the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
* Full Year 2025 Earnings <sup>p. 28</sup>
* February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''ContactInvestor us'Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
** Investor''Follow Relationsus'': +33 1 40 75 48 42www.axa.com <sup>p. 29</sup>
 
** investor.relations@axa.com <sup>p. 29</sup>
<div style="overflow-x:auto">
* '''Follow us''': www.axa.com <sup>p. 29</sup>
{| class="wikitable"
* '''Upcoming events''': <sup>p. 29</sup>
**|+ March:Meet Roadshowsour inmanagement Europeevent and USschedule <sup>p. 29</sup>
! style="text-align:left" | Date
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
|-
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup>
| style="text-align:left" | March
** September 21: AXA Investor Day in London <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
 
== Appendices ==
 
* Section divider for ''Appendices'' <sup>p. 30</sup>
 
=== Table of contents ===
* '''Debt and Invested Assets''' <sup>p. 31</sup>
 
* Additional P&C disclosures <sup>p. 36</sup>
* Additional''Debt IFRS17and disclosuresInvested Assets'' <sup>p. 4131</sup>
* Sustainability''Additional P&C disclosures'' <sup>p. 4436</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
Line 996 ⟶ 951:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross financial debt by type <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Tier 1FY24
! class="col-s" style="text-align:right" | Tier 2FY25
! class="col-s" style="text-align:right" | SeniorJan debt1st 2026
! class="col-s" style="text-align:right" | Total
|-
| style="text-align:left" | FY24Tier 1
| style="text-align:right" | 3.5
| style="text-align:right" | 10.8
| style="text-align:right" | 4.8
| style="text-align:right" | 194.26
| style="text-align:right" | 3.2
|-
| style="text-align:left" | FY25Tier 2
| style="text-align:right" | 310.58
| style="text-align:right" | 12.2
| style="text-align:right" | 411.63
| style="text-align:right" | 22.3
|-
| style="text-align:left" | JanSenior 1st 2026debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:right" | 11.3
| style="text-align:rightleft; font-weight:bold" | 3.2Total
| style="text-align:right; font-weight:bold" | 2019.32
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
Line 1,027 ⟶ 988:
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Tier 1
|-
| style="text-align:left" | 2025
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2027
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 01.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.25
| style="text-align:right" | 1.4
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | 0.5
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt contractual maturity <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2031-2039Grandfathered debt (contractual)
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ≥2040Tier 2 2030
| style="text-align:right" | 0.2
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | UndatedTier 2 ≥2040
| style="text-align:right" | 0.5
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
Line 1,103 ⟶ 1,043:
|+ Economic maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Tier 1
|-
| style="text-align:left" | 2025
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2028
| style="text-align:right" | 2.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 02.10
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.19
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 0.2
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt economic maturity <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2031-2039Grandfathered debt (economic)
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | ≥2040Tier 1 2026
| style="text-align:right" | 0.21
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | UndatedTier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Debt gearing: FY24 20.6%; FY25 22.3% <sup>p. 32</sup>
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* In January 2026, AXA called the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 <sup>p. 32</sup>
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
* In January 2026, AXA called the T1 GF €250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
* For Solvency 2 RT1 debt, the undated nature of the instrument is retained for this diagram, as it has no step-up <sup>p. 32</sup>
* '''Jan 1st 2026''' (End of the grandfathering period): Total 20.3; Tier 1 5.8 (o/w EUR 0.4bn redeemed in Jan 2026); Tier 2 11.3; Senior debt 3.2 <sup>p. 32</sup>
 
=== General Accountaccount invested assets ===
 
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Invested Totalassets Generalbreakdown Account invested assetsFY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ShareFY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | Real''o/w estateGovernment bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
 
=== Structured and private credit assets ===
* Duration gap: -0.4 year <sup>p. 33</sup>
* o/w Government bonds: 167 (37%) <sup>p. 33</sup>
* o/w Corporate bonds and loans: 121 (27%) <sup>p. 33</sup>
* o/w Other fixed income: 56 (13%) <sup>p. 33</sup>
** Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* Listed equities includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* Refer to the financial supplement for more details <sup>p. 33</sup>
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets by structuredStructured and private credit type,assets breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | % of total G/A portfolioFY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
</div>
 
* EUR''General 6bnAccount'' Dutch(G/A) mortgages,represents NHGthe guaranteedinvestment portfolio <sup>p. 34</sup>.
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 93% rated AAA-AA) <sup>p. 34</sup>
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
* Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
* o/w 54% participating <sup>p. 34</sup>
* G/A: General Account <sup>p. 34</sup>
 
=== Investment portfolio | Fixed Incomeincome reinvestment ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" | SegmentAsset mix
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Average rating
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | A
| style="text-align:right" | —
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
| style="text-align:right" | —
</div>
| style="text-align:right" | —
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | '''Total fixed income'''
| style="text-align:right; font-weight:bold" | 3.9%
| style="text-align:right" | —
| style="text-align:right" | '''3.9%'''
|}
</div>
 
* EURFixed 57income billionreinvestment fixedtotaled incomeEUR invested57bn atin 3.9%FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7 billion of Private & Structured Credit investedreinvestment of EUR 19.7bn at 4.7% (yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY) <sup>p. 35</sup>
** GradualStrategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* Government and Corporate bonds and related <sup>p. 35</sup>
* Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
 
*=== '''Table of contents''': ===
 
** 1. Debt and Invested Assets, p.31 <sup>p. 36</sup>
** 2.''Debt Additionaland P&CInvested disclosures,Assets'' p.36on page 31 <sup>p. 36</sup>
** 3. ''Additional IFRS17P&C disclosures,'' on page p.4136 <sup>p. 36</sup>
** 4.''Additional Sustainability,IFRS17 p.44disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,345 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business and geography, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" | SegmentLine of business
! class="col-s" style="text-align:right" | Line of business shareShare
! class="col-s" style="text-align:right" | Geography share
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
| style="text-align:right" | —
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | —
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | —
| style="text-align:right" | 19%
|}
</div>
 
* Well diversified across lines of business and geographies <sup>p. 37</sup>
<div style="overflow-x:auto">
* Leading market positions across lines <sup>p. 37</sup>
{| class="wikitable"
** Top 3 globally <sup>p. 37</sup>
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* ManagingCycle themanagement cycleis utilized to deliver consistent profitability <sup>p. 37</sup>
** (scatter plot) ''Property'Profitability': vs.high profitability, Exhigh ex-price growth (%)''':<sup>p. 37</sup>
*** Property''Specialty'': (medium-high profitability, medium-high ex-price growth) <sup>p. 37</sup>
*** Specialty''Casualty'': (medium profitability, medium ex-price growth) <sup>p. 37</sup>
*** Casualty''Professional (mediumlines'': lower profitability, lowlower ex-price growth) <sup>p. 37</sup>
*** Professional lines (low profitability, low ex-price growth) <sup>p. 37</sup>
 
=== P&C | Focus on Reservesreserves ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technical reserves ratios, FY18-FY25 <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS4)FY18
! class="col-s" style="text-align:right" | Claims reserves ratio (IFRS17)FY19
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS4)FY20
! class="col-s" style="text-align:right" | Technical reserves ratio (IFRS17)FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | FY18Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179%
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 213%
| style="text-align:right" | —
|-
| style="text-align:left" | FY19Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | 185%
| style="text-align:right" | —
| style="text-align:right" | 227%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193%
| style="text-align:right" | —
| style="text-align:right" | 233%
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" | FY21Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 188%213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | 226%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189%
| style="text-align:right" | 198%
| style="text-align:right" | 227%
| style="text-align:right" | 234%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195%
| style="text-align:right" | —
| style="text-align:right" | 232%
|-
| style="text-align:left" | FY24Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | 180%
| style="text-align:right" | —
| style="text-align:right" | 216%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175%
| style="text-align:right" | —
| style="text-align:right" | 210%234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* '''ClaimsTechnical reserves ratio'''definition (Netincludes net undiscounted claims reserves/Net earnedand premiums)unearned premium reserves <sup>p. 38</sup>.
* '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurancereinsurance Programprogram 1 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection, 2026 <sup>p. 39</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4.0
| style="text-align:right" | 600m
| style="text-align:right" | 4.0bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1
| style="text-align:right" | 450m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1
| style="text-align:right" | 400m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | 1.0
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
 
* (diagram) ''Reinsurance segment'' (illustrative):
* Stable retention levels maintained in 2026 as in 2025
* (diagram)Covered '''Reinsurance segmentvia (illustrative)''': Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
* Footnote 1: Excludes local reinsurance covers
* Footnote 2: Varying retention between MX and NA (EUR 400m MX, EUR 600m NA)
* Footnote 3: Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup>
! style="text-align:left" | PercentileReturn period / probability percentile
! class="col-s" style="text-align:right" | DeviationEUR billion
|-
| style="text-align:left" | 1/20y (95th percentile)
| class="col-s" style="text-align:right" | -EUR 1.2bn2
|-
| style="text-align:left" | 1/10y (90th percentile)
| class="col-s" style="text-align:right" | -EUR 0.8bn8
|-
| style="text-align:left" | 1/5y (80th percentile)
| class="col-s" style="text-align:right" | -EUR 0.4bn4
|-
| style="text-align:left" | Median (50th percentile)
| class="col-s" style="text-align:right" | EUR +0.1bn1
|-
| style="text-align:left" | 1/5y (20th percentile)
| class="col-s" style="text-align:right" | EUR +0.5bn5
|-
| style="text-align:left" | 1/10y (10th percentile)
| class="col-s" style="text-align:right" | EUR +0.7bn7
|-
| style="text-align:left" | 1/20y (5th percentile)
| class="col-s" style="text-align:right" | EUR +0.8bn8
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Average Expectedexpected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | EUR billionYear
! class="col-s" style="text-align:right" | 2025EUR billion
! class="col-s" style="text-align:right" | 2026Estimated impact on GEP
|-
| style="text-align:left" | Average Expected Nat Cat charges2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | 2ca. 4.75%
|-
| style="text-align:left" | Estimated impact on GEP2026
| class="col-s" style="text-align:right" | 42.5%7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
 
=== Table of contents ===
* Footnote 1: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
* (bar) '''More severe years (Negative deviation in ca. 40% of cases)''':
* (bar) '''Less severe years (Positive deviation in ca. 60% of cases)''':
 
* '''TableDebt ofand contents'Invested Assets'' <sup>p. 4131</sup>
** 1. Debt and''Additional InvestedP&C Assetsdisclosures'' <sup>p. 3136</sup>
** 2. ''Additional P&CIFRS17 disclosures'' <sup>p. 3641</sup>
** 3. Additional IFRS17 disclosures''Sustainability'' <sup>p. 4144</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
Line 1,558 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C Underlyingmargin Earningsanalysis walk,and FY24underlying toearnings FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Current Accident Year Undiscounted Technical Result'Margin''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Undiscounted Technical Margin
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | Gross''Current EarnedAccident PremiumsYear Discounting''
| style="text-align:right" | 57,656
| style="text-align:right" | +6%
|-
| style="text-align:left" | Current Accident Year Undiscounted Combined Ratio
| style="text-align:right" | 95.2%
| style="text-align:right" | -1.0pt
|-
| style="text-align:left; padding-left:1.5em" | o/w Nat Cats
| style="text-align:right" | 3.4%
| style="text-align:right" | -0.4pt
|-
| style="text-align:left" | Current Accident Year Discounting
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | Discounting''Prior RatioYears' (inReserve CombinedDevelopment Ratio points(PYD)''
| style="text-align:right" | -3.5%
| style="text-align:right" | +0.0pt
|-
| style="text-align:left" | Current Accident Year Net Claims reserves
| style="text-align:right" | 19.0bn
| style="text-align:right" | —
|-
| style="text-align:left" | Duration
| style="text-align:right" | 4.0 years
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Discount Rate
| style="text-align:right" | 2.8%
| style="text-align:right" | —
|-
| style="text-align:left" | Prior Years' Reserve Development (PYD)
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | PYD''Investment ratioIncome''
| style="text-align:right" | -1.1%
| style="text-align:right" | +0.7pt
|-
| style="text-align:left" | '''Financial Result'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | FY25''Insurance AverageFinance AssetsExpenses''
| style="text-align:right" | 115bn
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 3.5%
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield
| style="text-align:right" | 4.3%
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Finance Expenses
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | FY24''Underlying ReservesEarnings atbefore locked-in ratetax''
| style="text-align:right" | 71bn
| style="text-align:right" | —
|-
| style="text-align:left" | Liability book yield
| style="text-align:right" | 1.9%
| style="text-align:right" | —
|-
| style="text-align:left" | 2025 Insurance Finance Expenses (pre-tax)
| style="text-align:right" | ~-1.4bn
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,659 ⟶ 1,563:
| style="text-align:right" | -10
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" | +9%
| style="text-align:right" | —
|}
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
<div style="overflow-x:auto">
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
{| class="wikitable fintable"
|+* Sensitivity''Discounting toratio'' Current-3.5% Accident(+0.0pt Yearin discountCombined rateRatio changespoints) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
! style="text-align:left" | EUR billion
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | Impact
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
|-
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
| style="text-align:left" | +25bps
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
| style="text-align:right" | +0.2
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
|-
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
| style="text-align:left" | -25bps
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
| style="text-align:right" | -0.2
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
|}
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
</div>
 
=== L&H | Margin analysis ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | +25bps
| class="col-s" style="text-align:right" | ~-50
|-
| style="text-align:left" | -25bps
| class="col-s" style="text-align:right" | ~+50
|}
</div>
 
* Changes''L&H versusmargin FY24analysis'' atincludes constantscope FXimpact <sup>p. 4243</sup>.
* Reinvestment''Short-term yieldtechnical onmargin'' fixed+EUR income60m assetsto EUR 479m, including the recapture of Laya <sup>p. 4243</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve <sup>p. 42</sup>
* (flow) '''TechnicalAll year combined Result'ratio'' (In Euro million97.2%, pre-tax)improved 0.1pts <sup>p. 4243</sup>.
* (flow) '''FinancialLong-term technical Result'margin'' (In+EUR Euro156m million,to pre-tax)EUR 2,804m <sup>p. 4243</sup>.
* (flow)* ''CSM release''Underlying Earnings+EUR before215m tax'''to EUR 2,954m <sup>p. 4243</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
 
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
=== L&H | Margin analysis ===
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&HTechnical Underlyingand Earningsfinancial walk,results FY24in toEuro million, FY25pre-tax <sup>p. 43</sup>
! style="text-align:left" | EURTechnical millionand unlessFinancial otherwise mentionedResults
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Technical Result'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:right" | 479
| style="text-align:right" | +60
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
|-
| style="text-align:left" | All Year Combined Ratio
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pts
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | CSM release
| style="text-align:right" | 2,954
| style="text-align:right" | +215
|-
| style="text-align:left" | Technical experience
| style="text-align:right" | -150
| style="text-align:right" | -58
|-
| style="text-align:left" | '''Financial Result'''
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:right" | 98bn
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 2.5%
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield
| style="text-align:right" | 3.8%
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
! style="text-align:left" | Underlying Earnings
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | FY24Underlying ReservesEarnings atbefore locked-in ratetax
| style="text-align:right" | 62bn
| style="text-align:right" | —
|-
| style="text-align:left" | Liability book yield
| style="text-align:right" | 2.5%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | 4,229
| style="text-align:right" | +205
Line 1,779 ⟶ 1,635:
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | +65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
Line 1,785 ⟶ 1,641:
| style="text-align:right" | -51
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" | +7%
| style="text-align:right" | —
|}
</div>
 
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Keykey Sensitivitiessensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | EUR billionSensitivity
! class="col-s" style="text-align:right" | ValueImpact
|-
| style="text-align:left" | Baseline
Line 1,820 ⟶ 1,674:
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.87
|-
| style="text-align:left" | Equities +25%
Line 1,830 ⟶ 1,684:
</div>
 
=== Table of contents ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets <sup>p. 43</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | % of total G/A portfolio
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | 69
| style="text-align:right" | 15%
|}
</div>
 
* Includes''Debt scopeand impactInvested Assets'' <sup>p. 4331</sup>
* Changes''Additional versusP&C FY24 at constant FXdisclosures'' <sup>p. 4336</sup>
* Reinvestment''Additional yieldIFRS17 on fixed income assetsdisclosures'' <sup>p. 4341</sup>
* Incl. recapture of Laya''Sustainability'' <sup>p. 4344</sup>
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup>
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup>
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup>
* Strong diversification with EUR 8m average ticket <sup>p. 43</sup>
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup>
* o/w 54% participating <sup>p. 43</sup>
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup>
 
* '''Table of contents''' <sup>p. 44</sup>
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,893 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA'sESG Sustainability Targetstargets and 2025 Resultsachievements <sup>p. 45</sup>
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025Achieved Resultin 2025
|-
| style="text-align:left" | '''As a Global INVESTOR'''
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | Climate transition financing
Line 1,907 ⟶ 1,705:
|-
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | '''AsTransition aunderwriting Global(cumulative INSURER'''2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | P&C GWP to support transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 Cumulative(cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers by 2026
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | '''AsClimate aadaptation COMPANY'''training
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | >80,000
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Contribute to Net-Zero in absolute carbonCarbon emissions by 2030reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% Reduction against 2019
|-
| style="text-align:left" | Percentage of AXA Group employees engaged inEmployee volunteering activities by 2026
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
 
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup>
* Scope: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 <sup>p. 45</sup>
* Scope: AXA France, AXA Germany, AXA Switzerland, AXA XL, AXA Hong Kong, AXA Japan, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include: (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in the target for the 2024-2026 period, from >9,000 to >20,000 <sup>p. 45</sup>
* Inclusive insurance includes underserved populations and markets and modest income segments in mature markets <sup>p. 45</sup>
* Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 <sup>p. 45</sup>
* Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) <sup>p. 45</sup>
* Target revised in 2025 <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
Line 1,958 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG Ratings and Scores, 2025ratings <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! class="col-ms" style="text-align:right" | MetricScore
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | Percentile in Dow Jones Best-in-Class Europe & World indices
| class="col-m" style="text-align:right" | 97th
|-
| style="text-align:left" | S&P Global percentile
| class="col-ms" style="text-align:right" | Score97th
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | ScoreAAA
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ms" style="text-align:right" | ScoreB
| class="col-m" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | ESG17.0 Risk- Low Ratingrisk
| class="col-m" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-ms" style="text-align:right" | Score in FTSE4Good Index Series4.3/5
| class="col-m" style="text-align:right" | 4.3/5
|}
</div>
 
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more preciselyspecifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* Results''Morningstar asSustainalytics rating'': 2025 ESG Risk Rating of February17.0 6th, 2026Low risk <sup>p. 46</sup>.
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p.scope 47</sup>includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** China''Africa'': L&S,Morocco Thailand(insurance activities L&Sand holding), theNigeria Philippines(insurance L&Sactivities and P&Cholding), Indonesia L&S and IndiaEgypt (Lifeinsurance activities disposed on March 11, 2024 and holding) businesses which are fully consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa'EME-LATAM'': MoroccoMexico (insurance activities), andColombia holding)(insurance andactivities), NigeriaBrazil (insurance activities and holding), Egyptand Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to net income <sup>p. 47</sup>.
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** ''Transversal & Other'' scope includes AXA MediterraneanAssistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* ''Accounting standards''AXA Investmentcomparative Managersfigures (untilgoing Julyback 1,to 2025)''':2023 includesare AXAunder InvestmentIFRS17/9 Managers, Selectstandards (previouslyeffective referredJanuary to as1, Architas2023); andfigures Capzaprior whichto are2023 fullyhave consolidatednot andbeen Asianrestated joint ventures whichand are consolidatedpresented under the equity methodIFRS4 <sup>p. 47</sup>.
* Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>.
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>.
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>.
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>.
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* ''New Business Contractual Service Margin (NB CSM)'': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* '''New Business Contractual ServiceValue Marginmargin (NBNBV CSMmargin)''': a componentratio of the(i) carryingNBV, amount ofrepresenting the assetvalue or liability forof newly issued insurance contracts during the periodcurrent year, representing the unearned profit to be recognized as insurance contract services are(ii) providedPVEP <sup>p. 48</sup>.
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>.
* ''Present value of expected premiums (PVEP)'': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. Operating variance is net of reinsurance <sup>p. 48</sup>.
* ''Technical experience'Present': valueconsists of expectedthe premiumsimpacts (PVEP)''':on the newunderlying businessearnings volume,of equal to(i) the presentdifference value atbetween the timeexpected ofand incurred issuecash-flows of the totaldefined premiumsperiod, expected(ii) tothe berisk receivedadjustment overrelease, (iii) the policychanges termin <sup>p.onerous 48</sup>.contracts, PVEPand is(iv) discountedthe atother thelong-term referenceelements interestwhich rateare andmainly PVEPcomposed isof Groupnon-attributable shareexpenses <sup>p. 48</sup>.
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
* Thank you <sup>p. 49</sup>.
* Full Year 2025 Earnings <sup>p. 49</sup>.
* February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': Senior bond rating
* '''AAA''': Senior bond rating
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des marchés financiers
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* '''AXA UK'XL'': AXA UnitedCorporate Solutions and XL KingdomCatlin
* ''AY'': Accident Year
* '''AXA XL''': AXA XL (AXA's corporate and specialty risk division)
* '''AY'BBA'': AccidentBenefit-Bearing YearAccount
* '''BBA'CDP'': Benefit-BearingCarbon Disclosure AssetsProject
* '''BNP'CLO'': Banque NationaleCollateralized deLoan ParisObligation
* '''CDP'CRE'': CarbonCommercial DisclosureReal ProjectEstate
* ''CSA'': Corporate Sustainability Assessment
* '''CLO''': Collateralized Loan Obligation
* '''CRE'CSM'': CommercialContractual RealService EstateMargin
* ''CY'': Calendar Year
* '''CSA''': Corporate Sustainability Assessment
* '''CSM'DPS'': ContractualDividend ServicePer MarginShare
* '''CY'EME'': CalendarEmerging YearMarkets
* '''DPS'EOF'': DividendEligible PerOwn ShareFunds
* '''EME'EPS'': EmergingEarnings Per MarketsShare
* ''ESG'': Environmental, Social, and Governance
* '''EOF''': Eligible Own Funds
* ''ESMA'': European Securities and Markets Authority
* '''EPS''': Earnings Per Share
* ''EU'': European Union
* '''ESG''': Environmental, Social, and Governance
* ''EUR'': Euro
* '''ESMA''': European Securities and Markets Authority
* '''EU'FX'': EuropeanForeign UnionExchange
* ''GAAP'': Generally Accepted Accounting Principles
* '''EUR''': Euro
* '''FTSE'GBP'': Financial TimesGreat StockBritish ExchangePound
* '''FX'GEP'': ForeignGross Earned ExchangePremium
* ''GWP'': Gross Written Premiums
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP'HKD'': GrossHong EarnedKong PremiumsDollar
* '''GF'HY'': GrandfatheredHigh Yield
* '''GWP'IFE'': GrossInsurance WrittenFinance PremiumsExpenses
* ''IFRS'': International Financial Reporting Standards
* '''HKD''': Hong Kong Dollar
* '''HY'IG'': HighInvestment YieldGrade
* '''IFE'JPY'': Insurance FinanceJapanese ExpensesYen
* ''LATAM'': Latin America
* '''IFRS''': International Financial Reporting Standards
* '''IG'LFL'': Investment GradeLike-for-Like
* '''JPY'LTV'': Japanese YenLoan-to-Value
* ''MSCI'': Morgan Stanley Capital International
* '''LATAM''': Latin America
* '''LTV'NA'': Loan-to-ValueNorth America
* ''NB CSM'': New Business Contractual Service Margin
* '''MSCI''': Morgan Stanley Capital International
* '''MX'NBV'': MexicoNew Business Value
* '''NA'NHG'': NorthNationale Hypotheek AmericaGarantie
* ''NPS'': Net Promoter Score
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV'OCI'': NewOther BusinessComprehensive ValueIncome
* '''NHG'PAA'': NationaleParticipating HypotheekAccount GarantieAgreement
* '''NPS'PE'': Net PromoterPrivate ScoreEquity
* ''PVEP'': Present Value of Expected Profits
* '''OCI''': Other Comprehensive Income
* '''PAA'PYD'': PremiumPrior Years' AllocationReserve ApproachDevelopment
* '''PE'RCG'': PrivateReinsurance Capital EquityGeneration
* '''PVEP'ROE'': Present Value ofReturn Expectedon ProfitsEquity
* '''PYD'SCR'': Prior Years'Solvency ReserveCapital DevelopmentRequirement
* ''SHE'': Shareholders' Equity
* '''RCG''': Reinsurance Commission and Fees
* '''ROE'SME'': ReturnSmall and onMedium-sized EquityEnterprises
* ''TVOG'': Time Value of Options and Guarantees
* '''SCR''': Solvency Capital Requirement
* '''SHE'UEPS'': Shareholders'Underlying Earnings Per EquityShare
* ''UK'': United Kingdom
* '''SME''': Small and Medium-sized Enterprises
* ''US'': United States
* '''TVOG''': Time Value of Options and Guarantees
* '''UEPS'VAT'': Underlying EarningsValue PerAdded ShareTax
* '''UK'VFA'': UnitedVariable Fee KingdomApproach
* '''US''': United States
* '''USD''': United States Dollar
* '''VAT''': Value Added Tax
* '''VFA''': Variable Fee Approach